AZN
Price
$69.38
Change
-$0.17 (-0.24%)
Updated
Apr 25, 02:17 PM (EDT)
Capitalization
208.98B
4 days until earnings call
RHHVF
Price
$318.68
Change
+$5.58 (+1.78%)
Updated
Apr 24 closing price
Capitalization
250.69B
90 days until earnings call
Ad is loading...

AZN vs RHHVF

Header iconAZN vs RHHVF Comparison
Open Charts AZN vs RHHVFBanner chart's image
AstraZeneca
Price$69.38
Change-$0.17 (-0.24%)
Volume$3.05K
Capitalization208.98B
Roche Holding
Price$318.68
Change+$5.58 (+1.78%)
Volume$50.1K
Capitalization250.69B
AZN vs RHHVF Comparison Chart
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. RHHVF commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a StrongBuy and RHHVF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AZN: $69.55 vs. RHHVF: $318.68)
Brand notoriety: AZN: Notable vs. RHHVF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 56% vs. RHHVF: 1125%
Market capitalization -- AZN: $208.98B vs. RHHVF: $250.69B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green whileRHHVF’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • RHHVF’s FA Score: 2 green, 3 red.
According to our system of comparison, AZN is a better buy in the long-term than RHHVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 5 TA indicator(s) are bullish while RHHVF’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 5 bullish, 5 bearish.
  • RHHVF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZN is a better buy in the short-term than RHHVF.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.90% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was +1.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.09%. For the same industry, the average monthly price growth was -2.58%, and the average quarterly price growth was -8.77%.

Reported Earning Dates

AZN is expected to report earnings on Jul 24, 2025.

RHHVF is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.09% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($251B) has a higher market cap than AZN($209B). AZN has higher P/E ratio than RHHVF: AZN (35.30) vs RHHVF (19.34). RHHVF YTD gains are higher at: 13.813 vs. AZN (7.667). RHHVF has higher annual earnings (EBITDA): 19.1B vs. AZN (13.4B). RHHVF has more cash in the bank: 7.51B vs. AZN (5.86B). RHHVF has less debt than AZN: RHHVF (25.4B) vs AZN (28.6B). RHHVF has higher revenues than AZN: RHHVF (60B) vs AZN (45.8B).
AZNRHHVFAZN / RHHVF
Capitalization209B251B83%
EBITDA13.4B19.1B70%
Gain YTD7.66713.81356%
P/E Ratio35.3019.34182%
Revenue45.8B60B76%
Total Cash5.86B7.51B78%
Total Debt28.6B25.4B113%
FUNDAMENTALS RATINGS
AZN vs RHHVF: Fundamental Ratings
AZN
RHHVF
OUTLOOK RATING
1..100
6331
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
50100
PRICE GROWTH RATING
1..100
5753
P/E GROWTH RATING
1..100
6811
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (15) in the null industry is in the same range as AZN (25) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (30) in the Pharmaceuticals Major industry is significantly better than the same rating for RHHVF (100) in the null industry. This means that AZN’s stock grew significantly faster than RHHVF’s over the last 12 months.

AZN's SMR Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHVF (100) in the null industry. This means that AZN’s stock grew somewhat faster than RHHVF’s over the last 12 months.

RHHVF's Price Growth Rating (53) in the null industry is in the same range as AZN (57) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to AZN’s over the last 12 months.

RHHVF's P/E Growth Rating (11) in the null industry is somewhat better than the same rating for AZN (68) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew somewhat faster than AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNRHHVF
RSI
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 10 days ago
43%
Bearish Trend 19 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGEX20.78N/A
N/A
Guinness Atkinson Global Energy
HRCVX18.94N/A
N/A
Carillon Eagle Growth & Income A
OMSNX23.25N/A
N/A
Invesco Main Street All Cap R
STSCX35.12N/A
N/A
Sterling Capital SmCp Val Instl
VSORX40.66N/A
N/A
Victory Sycamore Small Company Opp R6

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with NVS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+1.52%
NVS - AZN
58%
Loosely correlated
+0.94%
GSK - AZN
49%
Loosely correlated
+1.27%
SNY - AZN
48%
Loosely correlated
+0.98%
AZNCF - AZN
48%
Loosely correlated
+1.10%
PFE - AZN
47%
Loosely correlated
+1.74%
More

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
+1.78%
RHHBY - RHHVF
65%
Loosely correlated
+1.56%
JNJ - RHHVF
31%
Poorly correlated
-0.29%
NVS - RHHVF
27%
Poorly correlated
+0.94%
AZN - RHHVF
26%
Poorly correlated
+1.52%
RHHBF - RHHVF
25%
Poorly correlated
+6.89%
More